ZYTOMICS Trademark
Trademark Overview
On Wednesday, November 1, 2023, a trademark application was filed for ZYTOMICS with the United States Patent and Trademark Office. The USPTO has given the ZYTOMICS trademark a serial number of 79391171. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, September 15, 2025. This trademark is owned by ZytoVision GmbH. The ZYTOMICS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Scientific research and laboratory apparatus in the nature of analysis systems for use in the analysis of proteins, nucleic acids, human cells, and human tissues; educational apparatus and simulators in the nature of medical diagnostic simulators for use as teaching aids for medical procedures; analysis apparatus in the nature of diagnostic apparatus for research laboratory use for conducting and evaluating histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry, and isolation of biomolecules including DNA, RNA and proteins; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; analysis apparatus for research laboratories in the nature of diagnostic apparatus for measuring, testing and examining tissue, cells and biomolecules including DNA, RNA and protein...
Pharmaceuticals and medical preparations for use in chemotherapy and cancer diagnostics; diagnostic preparations for medical purposes; diagnostic preparations for in-vitro testing for medical use; pharmaceuticals, pharmaceutical preparations, medical products in the nature of diagnostic preparations, medical preparations, chemical products in the nature of chemical reagents, chemical preparations, biochemical products in the nature of chemical reagents, and biochemical preparations, all for use in chemotherapy and cancer diagnostics for medical use; pharmaceutical, medical, chemical and biochemical preparations for medical purposes in the fields of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry services, and isolation of biomolecules including DNA, RNA and proteins; nucleic acids in the nat...
Business management consultancy and advisory services; operation of a business for others, namely, holding company services; holding company services performed for third parties, namely, business management, business administration, providing office functions; holding company services performed for third parties, namely developing marketing strategy, professional business and organisational consultancy and management of the business interests of others and legally independent companies; business management and organization consultancy; advisory services for business management; business administration; providing office functions; planning and monitoring of business developments with regard to organisational matters in the nature of business organisational consultation
Chemicals for use in industry and science; chemicals and biochemicals for use in science in the fields of pathology, genetics, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology, laboratory medicine; chemicals and biochemicals for use in science in the fields of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry services, and isolation of biomolecules including DNA, RNA and proteins; nucleic acids in the nature of DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids, for scientific purposes; proteins in the nature of peptide substrates, recombinant proteins and marked proteins for scientific and medical research; antibodies for scientific purposes; DNA probes being biochemical preparations for scientific purposes; RNA pr...
Medical services; medical diagnostic services; medical in-vitro diagnostic services for medical and pharmaceutical purposes; medical services in the fields of pathology, genetic science, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology and laboratory medicine; medical diagnostic services using histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry and isolation of biomolecules including DNA, RNA and proteins; medical counseling; pharmaceutical services in the nature of pharmaceutical advice in the field of diagnosing and treating cancer; pharmaceutical advice; medical and health clinic services relating to DNA, genetics and genetic testing; medical pathology services; genetic testing for medical purposes
Medical apparatus and instruments for use in cancer diagnostic and treatment procedures; medical instruments for use in cancer diagnostic and treatment procedures; medical analytical apparatus for analyzing human cells and tissues for the presence of cancerous cells for medical purposes; automatic analyzers for medical diagnosis of cancer in human cells and tissues; physical analyzers for diagnosing cancer for medical use; genetic testing apparatus for medical purposes
Science and technology services, namely, research in the field of cancer; medical research laboratory services; development of pharmaceutical preparations and medicines; clinical research in the field of cancer diagnosis and treatment for medical and scientific purposes; research relating to biotechnology; scientific research consultancy services; biological analysis, biochemical analysis, chemical analysis, scientific analysis, all being scientific research; scientific research in the field of genetics and genetic engineering
General Information
| Serial Number | 79391171 |
| Word Mark | ZYTOMICS |
| Filing Date | Wednesday, November 1, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, September 15, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Scientific research and laboratory apparatus in the nature of analysis systems for use in the analysis of proteins, nucleic acids, human cells, and human tissues; educational apparatus and simulators in the nature of medical diagnostic simulators for use as teaching aids for medical procedures; analysis apparatus in the nature of diagnostic apparatus for research laboratory use for conducting and evaluating histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry, and isolation of biomolecules including DNA, RNA and proteins; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; analysis apparatus for research laboratories in the nature of diagnostic apparatus for measuring, testing and examining tissue, cells and biomolecules including DNA, RNA and proteins |
| Goods and Services | Pharmaceuticals and medical preparations for use in chemotherapy and cancer diagnostics; diagnostic preparations for medical purposes; diagnostic preparations for in-vitro testing for medical use; pharmaceuticals, pharmaceutical preparations, medical products in the nature of diagnostic preparations, medical preparations, chemical products in the nature of chemical reagents, chemical preparations, biochemical products in the nature of chemical reagents, and biochemical preparations, all for use in chemotherapy and cancer diagnostics for medical use; pharmaceutical, medical, chemical and biochemical preparations for medical purposes in the fields of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry services, and isolation of biomolecules including DNA, RNA and proteins; nucleic acids in the nature of DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids for medical purposes; proteins in the nature of peptide substrates, recombinant proteins and marked proteins for use in chemotherapy and cancer diagnostics for medical purposes; antibodies for medical purposes; DNA probes being biochemical preparations for chemotherapy and cancer diagnostics for medical use; RNA probes being biochemical preparations for chemotherapy and cancer diagnostics for medical use; oligonucleotide probes being biochemical preparations for chemotherapy and cancer diagnostics for medical use; biological tissue, namely, human stem cells, human somatic cells, human cancer cells, human tissue, and human tissue sections for use in chemotherapy and cancer diagnostics; nucleic acids, proteins, human somatic cells, human cancer cells and human stem cells immobilised on carriers for medical diagnostic purposes |
| Goods and Services | Business management consultancy and advisory services; operation of a business for others, namely, holding company services; holding company services performed for third parties, namely, business management, business administration, providing office functions; holding company services performed for third parties, namely developing marketing strategy, professional business and organisational consultancy and management of the business interests of others and legally independent companies; business management and organization consultancy; advisory services for business management; business administration; providing office functions; planning and monitoring of business developments with regard to organisational matters in the nature of business organisational consultation |
| Goods and Services | Chemicals for use in industry and science; chemicals and biochemicals for use in science in the fields of pathology, genetics, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology, laboratory medicine; chemicals and biochemicals for use in science in the fields of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry services, and isolation of biomolecules including DNA, RNA and proteins; nucleic acids in the nature of DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids, for scientific purposes; proteins in the nature of peptide substrates, recombinant proteins and marked proteins for scientific and medical research; antibodies for scientific purposes; DNA probes being biochemical preparations for scientific purposes; RNA probes being biochemical preparations for scientific purposes; oligonucleotide probes being biochemical preparations for scientific purposes; biological tissue, namely, human stem cells, human somatic cells, human cancer cells, human tissue, human tissue sections, for scientific and medical research; nucleic acids, proteins, human somatic cells, human cancer cells, and stem cells immobilised on carriers for scientific and medical research |
| Goods and Services | Medical services; medical diagnostic services; medical in-vitro diagnostic services for medical and pharmaceutical purposes; medical services in the fields of pathology, genetic science, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology and laboratory medicine; medical diagnostic services using histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry and isolation of biomolecules including DNA, RNA and proteins; medical counseling; pharmaceutical services in the nature of pharmaceutical advice in the field of diagnosing and treating cancer; pharmaceutical advice; medical and health clinic services relating to DNA, genetics and genetic testing; medical pathology services; genetic testing for medical purposes |
| Goods and Services | Medical apparatus and instruments for use in cancer diagnostic and treatment procedures; medical instruments for use in cancer diagnostic and treatment procedures; medical analytical apparatus for analyzing human cells and tissues for the presence of cancerous cells for medical purposes; automatic analyzers for medical diagnosis of cancer in human cells and tissues; physical analyzers for diagnosing cancer for medical use; genetic testing apparatus for medical purposes |
| Goods and Services | Science and technology services, namely, research in the field of cancer; medical research laboratory services; development of pharmaceutical preparations and medicines; clinical research in the field of cancer diagnosis and treatment for medical and scientific purposes; research relating to biotechnology; scientific research consultancy services; biological analysis, biochemical analysis, chemical analysis, scientific analysis, all being scientific research; scientific research in the field of genetics and genetic engineering |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 14, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 14, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 14, 2024 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 14, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 14, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 14, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 14, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ZytoVision GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
Trademark Events
| Event Date | Event Description |
| Thursday, March 14, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 22, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, April 24, 2024 | APPLICATION FILING RECEIPT MAILED |
| Thursday, May 30, 2024 | ASSIGNED TO EXAMINER |
| Friday, May 31, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 4, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, January 22, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sunday, February 9, 2025 | REFUSAL PROCESSED BY IB |
| Thursday, March 6, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 6, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 4, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, June 4, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, June 4, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, December 27, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, January 22, 2025 | REFUSAL PROCESSED BY MPU |
| Thursday, March 6, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 31, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, July 31, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, July 31, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 13, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, August 26, 2025 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Friday, August 29, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, September 10, 2025 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Thursday, July 31, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, July 31, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 13, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, September 15, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 15, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, September 15, 2025 | NON-FINAL ACTION E-MAILED |
